A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 39
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : APCR
Long Form : activated protein C
No. Year Title Co-occurring Abbreviation
2015 The role of hypercoagulability in ischemic colitis. AT, CI, IC, LA, MTHFR, OR, PAI-1, PC
2007 Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review. CRP, HT
2006 Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease. CD
2006 What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease? CD, IBD, UC
2005 Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation. FV, FV, OLT, TEs
2004 Sex hormone--binding globulin--a surrogate marker for the prothrombotic effects of combined oral contraceptives. COC, DG/EE, LNG/EE, SHBG, VTE
2003 Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients. AT, PC, PS
2003 [Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis]. DVT, PC, PS, SSP-PCR
2002 [A study on the deficiency of anticoagulant proteins in Chinese patients with deep venous thrombosis]. APC-SR, ATIII, PCR-RFLP
10  2001 Genetic thrombophilia in patients with retinal vascular occlusion. DVT
11  2001 Resistance to activated protein C--frequent etiologic factor for venous thrombosis. ---
12  2001 The role of protein C, protein S, and resistance to activated protein C in Legg-Perthes disease. ---
13  2001 [Evaluation of resistance to activated protein C in myocardial infarction patients]. ---
14  2000 Combined genetic defect (homogeneity for factor V Leiden and heterogeneity for prothrombin G20210A allele), in a young patient, with recurrent deep vein thrombosis and serious postphlebitic syndrome--a case report. 3'UTR, VT
15  2000 Resistance to activated protein C and FV leiden mutation in patients with a history of acute myocardial infarction or primary hypertension. AMI, PH
16  2000 Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulas. DAVFs, FV
17  1999 Activated protein C resistance: a study among 60 thromboembolic patients in the Singapore population. PCR
18  1999 Pathogenetic factors underlying juvenile deep vein thrombosis (DVT) in Indians. DVT, LA
19  1999 [Pulmonary thromboembolism in a female with resistance to activated protein C]. ---
20  1999 [Thrombophilic states]. HCII, PAI-1, TPA
21  1998 Association of resistance to activated protein C and dural arteriovenous fistulas. DAVFs, FV
22  1998 Congenital resistance to activated protein C in patients with lupus anticoagulants: evaluation of two functional assays. LAs
23  1998 Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. aPL, beta2GPI, dRVVT, FVa, KCT, SD
24  1998 Exogenous estrogen may exacerbate thrombophilia, impair bone healing and contribute to development of chronic facial pain. ---
25  1998 Resistance to activated protein C as a risk factor of stroke in a thalassemic patient. ---
26  1997 Arginine506 to glutamin mutation in the factor V gene in infancy and childhood: evidence of fibrinolytic impairment. Arg506, Gln, PAI, tPA, uPA
27  1997 Determination of coagulation inhibitor levels and resistance to activated protein C in patients undergoing gastric surgery for benign and malignant disorders. AT, HCII, PC, PS, TFPI
28  1997 Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease. LA, VTD
29  1997 Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT. ---
30  1997 [Resistance to activated protein C by mutation of the factor V gene. Most frequent blood coagulation defect in venous thromboses]. ---
31  1996 APC resistance in neonates and infants: adjustment of the APTT-based method. ---
32  1996 Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma. APTT
33  1996 Mutation in the gene coding for coagulation factor V and resistance to activated protein C: detection of the genetic mutation by oligonucleotide ligation assay using a semi-automated system. OLA
34  1996 Oligonucleotide ligation assay for detection of the factor V mutation (Arg506-->Gln) causing protein C resistance. FV, OLA, PCR
35  1996 Plasma thrombomodulin concentrations in infants and children undergoing cardiac catheterization. TM
36  1996 Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. APTT
37  1996 Resistance to activated protein C (APCR): reference values of APC-ratios for children. ---
38  1996 Resistance to activated protein C, associated with oral contraceptives use; effect of formulations, duration of assumption, and doses of oestro-progestins. APC-SR, OCs
39  1995 Resistance to activated protein C (APCR) in children with acute lymphoblastic leukaemia--the need for a prospective multicentre study. ---